Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cerebrospinal Fluid Biomarkers of Myotonic Dystrophy — Stella

Home/Myotonic Dystrophy Type 1/

View on ClinicalTrials.gov

Recruiting

Back to Myotonic Dystrophy Type 1 trials

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Sponsor

Massachusetts General Hospital

Enrollment target

~88 participants

Started

August 2022

Primary completion

August 2027

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.